Aquestive Therapeutics
Yahoo Finance • 12 hours ago
Aquestive Therapeutics to Present Data at the 2026 ACAAI Annual Meeting
Aquestive Therapeutics, Inc. WARREN, N.J., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) ("Aquestive" or the "Company"), a biopharmaceutical company advancing medicines to bring meaningful improvement to pa... Full story
Yahoo Finance • 2 days ago
Here are the major earnings after the close Tuesday
Major earnings expected after the bell on Tuesday include: * Advanced Micro Devices (AMD [https://seekingalpha.com/symbol/AMD]) * Super Micro Computer (SMCI [https://seekingalpha.com/symbol/SMCI]) * Block (XYZ [https://seekingalpha.... Full story
Yahoo Finance • 22 days ago
Aquestive rises on licensing deal with Eton for antiseizure therapy
[Two coloured ropes knotted together] Richard Drury Shares of Aquestive Therapeutics (AQST [https://seekingalpha.com/symbol/AQST]) rose in premarket trading on Wednesday after the company reached an exclusive license agreement with Eton P... Full story
- ETON
Mentioned:
Yahoo Finance • 3 months ago
Aquestive Therapeutics Q2 Earnings Call Highlights
Key Points Interested in Aquestive Therapeutics, Inc.? Here are five stocks we like better. Aquestive plans to resubmit Anaphylm's FDA application before the end of Q3 after revised packaging and instructions substantially reduced pouch-o... Full story
Yahoo Finance • 6 months ago
Aquestive Therapeutics Q1 Earnings Call Highlights
Key Points Interested in Aquestive Therapeutics, Inc.? Here are five stocks we like better. Anaphylm remains the main focus: Aquestive still plans to resubmit its NDA for the epinephrine sublingual film in Q3 2026, pending FDA feedback on... Full story
Yahoo Finance • 6 months ago
Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree
WARREN, N.J., May 12, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative... Full story
Yahoo Finance • 6 months ago
AQST DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action – AQST
NEW YORK, May 02, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aquestive Therapeutics, Inc. (NASDAQ: AQST) between June 16, 2025 and January 8, 2026, both dates inc... Full story
Yahoo Finance • 6 months ago
Bragar Eagel & Squire, P.C. Reminds Aquestive Therapeutics, Inc. Investors with Large Losses They Have Until Monday May 4th to Seek Lead Plaintiff Role
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Aquestive (AQST) To Contact Him Directly To Discuss Their Options If you purchased or acquired Aquestive securities between June 16,... Full story
Yahoo Finance • 6 months ago
AQST DEADLINE: ROSEN, HIGHLY RECOGNIZED INVESTOR RIGHTS COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 4 Deadline in Securities Class Action – AQST
NEW YORK, April 25, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aquestive Therapeutics, Inc. (NASDAQ: AQST) between June 16, 2025 and January 8, 2026, both dates i... Full story
Yahoo Finance • 6 months ago
AQST Shareholder Alert: Aquestive Therapeutics, Inc. Securities Class Action Lawsuit - Investors Should Contact The Gross Law Firm
NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Aquestive Therapeutics, Inc. (NASDAQ: AQST). Shareholders who purchased shares of AQST during the class period listed are enc... Full story
Yahoo Finance • 6 months ago
Bronstein, Gewirtz & Grossman LLC Urges Aquestive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Aquestive Therapeutics, Inc. (NASDAQ: AQST) a... Full story
Yahoo Finance • 7 months ago
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AQST
NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aquestive Therapeutics, Inc. (NASDAQ: AQST) between June 16, 2025 and January 8, 2026, both dates i... Full story
Yahoo Finance • 7 months ago
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – AQST
NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Aquestive Therapeutics, Inc. (“Aquestive” or the “Company”) (NASDAQ: AQST). Such investors are advised to contact D... Full story
Yahoo Finance • 7 months ago
Holzer & Holzer, LLC Reminds Investors of Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Aquestive Therapeutics, Inc. (AQST), Nektar Therapeutics (NKTR), and Eos Energy Enterprises, Inc. (EOSE)
ATLANTA, April 06, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: Aquestive Therapeutics, Inc. (AQST) The shareholder class... Full story
Yahoo Finance • 7 months ago
ROSEN, LEADING INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AQST
NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aquestive Therapeutics, Inc. (NASDAQ: AQST) between June 16, 2025 and January 8, 2026, both dates i... Full story
Yahoo Finance • 7 months ago
AQST Stockholders Have Rights – If You Lost Money Investing in Aquestive Therapeutics, Inc. Contact the Firm for Information About Recovering Your Losses
SAN DIEGO, March 31, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Aquestive Therapeutics, Inc. (NASDAQ: AQST) securities between J... Full story
Yahoo Finance • 7 months ago
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aquestive Therapeutics, Inc. (AQST)
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Aquestive Thera... Full story
Yahoo Finance • 7 months ago
Aquestive Therapeutics (AQST) Awaits Anaphylm NDA Approval in Q3
Aquestive Therapeutics Inc. (NASDAQ:AQST) is one of the 7 best small-cap drug manufacturing stocks to buy according to hedge funds. On March 5, Alliance Global reduced the firm’s price target on Aquestive Therapeutics Inc. (NASDAQ:AQST) f... Full story
Yahoo Finance • 7 months ago
Bragar Eagel & Squire, P.C. Reminds Aquestive Therapeutics, Inc. Investors with Significant Losses to Contact the Firm Before Upcoming Lead Plaintiff Deadline
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Aquestive (AQST) To Contact Him Directly To Discuss Their Options If you purchased or acquired Aquestive securities between June 16,... Full story
Yahoo Finance • 7 months ago
Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors
LOS ANGELES, March 26, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Aquestive Therapeutics, Inc., (“Aquestive” or the "Company") (NASDAQ: AQST) investors off a class action on behalf of investors that bought securities between J... Full story